Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment Validation for Myofascial Pain

NCT: NCT07133139 · RECRUITING

NCT IDNCT07133139
StatusRECRUITING
Start Date2025-10-06
Completion2029-12-31
SponsorAjay Wasan, MD, Msc (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to see if a body test called the NUN biomarker can track changes in chronic low back pain after dry needling and predict who will feel better. This study is for adults with chronic low back pain from muscle pain (Myofacial Pain). The main questions are: * Does the biomarker drop when pain improves? * Can it predict who benefits most? * Do higher starting levels mean better results with real dry needling? Investigators will compare real and fake (sham) dry needling using ultrasound, muscle pressure tests, and pain reports before and after treatment.

Frequently Asked Questions

What is Treatment Validation for Myofascial Pain?

Treatment Validation for Myofascial Pain is a clinical trial registered under NCT07133139. Current status: RECRUITING.

What is the status of NCT07133139?

The current status of NCT07133139 (Treatment Validation for Myofascial Pain) is: RECRUITING.

When did Treatment Validation for Myofascial Pain start?

Treatment Validation for Myofascial Pain started on 2025-10-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑